首页 | 本学科首页   官方微博 | 高级检索  
     

微卡对致敏小鼠气道炎症和Th1/Th2比例变化的影响
引用本文:谢强敏,卞如濂,吴康松,郑行. 微卡对致敏小鼠气道炎症和Th1/Th2比例变化的影响[J]. 中华结核和呼吸杂志, 2002, 25(8): 488-491
作者姓名:谢强敏  卞如濂  吴康松  郑行
作者单位:310031,杭州,浙江大学医学院国家药品监督管理局浙江呼吸药物研究实验室
摘    要:目的 观察母牛分支杆菌菌苗 (微卡 )对致敏小鼠抗原攻击后气道炎症、Th1和Th2细胞因子的比例变化 ,评估微卡防治哮喘的药理作用。方法 小鼠分 9组 ,每组 7~ 1 0只。采用皮肤划痕、气管滴入、肌肉注射三种给药途径单次给药 ,观察比较微卡菌苗对致敏小鼠吸入抗原后支气管肺泡灌洗液 (BALF)中炎症细胞 ,γ干扰素 (IFN γ)和白细胞介素 4(IL 4)水平变化的影响和作用强度。结果 经皮肤划痕 (2 .2 5μg)、气管内滴入 (2 .2 5μg)、肌肉注射 (2 2 .5μg)后BALF中炎症细胞总数分别为 (6± 6)× 1 0 8/L、(7± 6)× 1 0 8/L、(8± 5)× 1 0 8/ml,与模型组 (1 5± 8)× 1 0 8/L比较 (P <0 .0 5) ;嗜酸细胞 :皮肤划痕组 (2 2 5μg)为 0 7± 0 5、气管内滴入 (2 2 5μg)为 1 6± 1 9、肌肉注射 (7 5μg)为 2 6±1 3、肌肉注射组 (2 2 .5μg)为 1 .40± 1 .2 0 ,与模型组 (4.90± 4 .60 )比较 (P <0 .0 5或 <0 .0 1 ) ;皮肤划痕组 (2 .2 5μg)BALF中IFN γ水平为 (2 89± 57)pg/ml、气管滴入组 (2 .2 5μg)为 (335± 57)pg/ml、肌肉注射组 (2 2 .5μg)为 (31 3± 49)pg/ml,与模型组 (2 1 6± 42 )pg/ml比较 (P <0 .0 5或 0 .0 1 ) ;皮肤划痕组(2 .2 5μg) BALF中IL 4水平为 (63± 1 9)pg/ml、气管滴入组

关 键 词:小鼠 气道炎症 微卡 炎症细胞 细胞因子 哮喘 Th1/Th2 药理作用
修稿时间:2001-11-12

Effects of vaccae on airway inflammation and Th1/Th2 cytokines in sensitized mice
XIE Qiangmin,BIAN Rulian,WU Kangsong,ZHENG Xing. Zhejiang Respiratory Drugs Research Laboratory of State Drugs Administration of China,Medical School of Zhejiang University,Hangzhou ,China. Effects of vaccae on airway inflammation and Th1/Th2 cytokines in sensitized mice[J]. Chinese journal of tuberculosis and respiratory diseases, 2002, 25(8): 488-491
Authors:XIE Qiangmin  BIAN Rulian  WU Kangsong  ZHENG Xing. Zhejiang Respiratory Drugs Research Laboratory of State Drugs Administration of China  Medical School of Zhejiang University  Hangzhou   China
Affiliation:Zhejiang Respiratory Drugs Research Laboratory of State Drugs Administration of China, Medical School of Zhejiang University, Hangzhou 310031, China.
Abstract:OBJECTIVE: To study the inhibitory effect of Mycobacterium vaccae (M. vaccae) on the accumulation of airway inflammatory cells and its regulatory effect on IFN-gamma/IL-4 balance in bronchoalveolar lavage fluids (BALF) from ovalbumin (OVA)-challenged and sensitized mice, therefore to provide experimental evidence for the application of M. vaccae in the treatment of asthma. METHODS: Sensitized mice were given a single dose of M. vaccae 3 days before inhaled OVA-challenge by one of the three routes: intramuscularly (i.m.), by intratracheal (i.t) instillation or by cutaneous scarification (c.s). Accumulation of inflammatory cells, IFN-gamma and IL-4 levels in BALF were determined. RESULTS: The total numbers of the inflammatory cells in BALF from the M. vaccae 2.25 micro g (per mouse) c.s group (6 +/- 6) x 10(8)/L, the 2.25 microgram i.t group (7 +/- 6) x 10(8)/L and the 22.5 micro g i.m group (8 +/- 5) x 10(8)/L, were significantly lower than that of the model control (15 +/- 8) x 10(8)/L (P < 0.05). Eosinophils in the 2.25 microgram c.s group 0.7 +/- 0.5, the 2.25 microgram i.t group 1.6 +/- 1.9, the 7.5 micro g i.m group 2.6 +/- 1.3 and the 22.5 microgram i.m group 1.40 +/- 1.20, were significantly lower than those in the model group 4.90 +/- 4.60 (P < 0.05 and P < 0.01). IFN-gamma levels in the 2.25 microgram c.s group (289 +/- 57) pg/ml, the 2.25 micro g i.t group (335 +/- 57) pg/ml and the 22.5 micro g i.m group (313 +/- 49) pg/ml, were significantly higher than that in the model group (216 +/- 42) pg/ml (P < 0.05 and P < 0.01). IL-4 levels in the 2.25 microgram c.s group (63 +/- 19) pg/ml, the 2.25 microgram i.t group (8 +/- 5) pg/ml and the 22.5 micro g i.m group (13 +/- 6) pg/ml, were significantly lower than that in the model group (93 +/- 25) pg/ml (P < 0.05 and P < 0.01). The inhibitory effect on eosinophil accumulation by i.t or c.s M. vaccae was 10 times stronger than that by i.m M. vaccae. i.t M. vaccae was the most effective in regulating the IFN-gamma/IL-4 ratio. CONCLUSION: M. vaccae inhibited airway inflammation via regulating Th1/Th2 balance, suggesting that it may be beneficial in the treatment of asthma.
Keywords:Vaccae  Mycobacterium vaccae  Inflammatory cells  Cytokine  Asthma
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号